← All stories
Markets

STAT+: In wake of boy’s death, gene editing experts dissect Huidagene’s decisions

1 source ·1 article ·3h ago

Experts question technical improvements Huidagene tried when using a Duchenne muscular dystrophy treatment strategy largely abandoned by U.S. companies.

Covered by 1 outlet

All coverage · 1 article